Related Experiment Videos
Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy
The New England Journal of Medicine
|February 20, 1986
Summary
Plasma exchange shows efficacy in treating chronic inflammatory demyelinating polyradiculoneuropathy. This prospective trial found significant improvements in nerve conduction and neurologic function for patients undergoing plasma exchange compared to sham treatment.
Area of Science:
- Neurology
- Immunology
Background:
- Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a debilitating autoimmune disorder affecting peripheral nerves.
- Previous reports suggest plasma exchange (PLEX) may be beneficial in managing CIDP.
Purpose of the Study:
- To prospectively evaluate the efficacy of plasma exchange in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
- To assess the impact of plasma exchange on nerve conduction studies and neurological disability scores.
Main Methods:
- A prospective, double-blind, randomized controlled trial was conducted.
- Patients with static or worsening CIDP were assigned to receive either plasma exchange (n=15) or sham exchange (n=14) for three weeks.
- Nerve conduction measurements and neurological disability scores were assessed before and after the intervention.
Main Results:
- Statistically significant improvements in combined nerve conduction measurements (motor, proximal, velocity, amplitude) were observed in the plasma exchange group compared to the sham group.
- Five patients receiving plasma exchange showed significant improvement in their neurologic-disability score (P=0.025).
- Subset scores for weakness and reflex also improved in four patients (P<0.057) undergoing plasma exchange.
Conclusions:
- Plasma exchange demonstrates an ameliorating effect on neurologic dysfunction and nerve conduction in some patients with CIDP.
- The study suggests that humoral factors may play a role in the pathogenesis of CIDP, as plasma was replaced with normal serum albumin.
- Individual patient responses to plasma exchange vary, indicating a need for personalized treatment approaches in CIDP management.